Heart Health Ltd 11204592 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is the provision of well-being application services. Digita Accounts Production Advanced 6.30.9574.0 true true 11204592 2023-03-01 2024-02-29 11204592 2024-02-29 11204592 bus:OrdinaryShareClass1 2024-02-29 11204592 core:CurrentFinancialInstruments 2024-02-29 11204592 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 11204592 core:OtherResidualIntangibleAssets 2024-02-29 11204592 core:FurnitureFittingsToolsEquipment 2024-02-29 11204592 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2024-02-29 11204592 bus:SmallEntities 2023-03-01 2024-02-29 11204592 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 11204592 bus:FilletedAccounts 2023-03-01 2024-02-29 11204592 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 11204592 bus:RegisteredOffice 2023-03-01 2024-02-29 11204592 bus:Director1 2023-03-01 2024-02-29 11204592 bus:Director2 2023-03-01 2024-02-29 11204592 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 11204592 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 11204592 core:IntangibleAssetsOtherThanGoodwill 2023-03-01 2024-02-29 11204592 core:OtherResidualIntangibleAssets 2023-03-01 2024-02-29 11204592 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 11204592 core:OfficeEquipment 2023-03-01 2024-02-29 11204592 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2023-03-01 2024-02-29 11204592 countries:England 2023-03-01 2024-02-29 11204592 2023-02-28 11204592 core:OtherResidualIntangibleAssets 2023-02-28 11204592 core:FurnitureFittingsToolsEquipment 2023-02-28 11204592 2022-03-01 2023-02-28 11204592 2023-02-28 11204592 bus:OrdinaryShareClass1 2023-02-28 11204592 core:CurrentFinancialInstruments 2023-02-28 11204592 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 11204592 core:OtherResidualIntangibleAssets 2023-02-28 11204592 core:FurnitureFittingsToolsEquipment 2023-02-28 11204592 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2023-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11204592

Heart Health Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 29 February 2024

 

Heart Health Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Heart Health Ltd

Company Information

Directors

P Ramrakha

S Ramrakha

Registered office

1 Ledborough Wood
Beaconsfield
Bucks
HP9 2DJ

Accountants

Tax Innovations Limited
Innovations House
19 Staple Gardens
Winchester
Hampshire
SO23 8SR

 

Heart Health Ltd

(Registration number: 11204592)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

5

23,501

28,689

Tangible assets

6

1,657

3,077

 

25,158

31,766

Current assets

 

Debtors

7

2

81

Cash at bank and in hand

 

46,230

43,445

 

46,232

43,526

Creditors: Amounts falling due within one year

8

(195,556)

(192,111)

Net current liabilities

 

(149,324)

(148,585)

Net liabilities

 

(124,166)

(116,819)

Capital and reserves

 

Called up share capital

9

2

2

Retained earnings

(124,168)

(116,821)

Shareholders' deficit

 

(124,166)

(116,819)

 

Heart Health Ltd

(Registration number: 11204592)
Balance Sheet as at 29 February 2024

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 November 2024 and signed on its behalf by:
 

.........................................
S Ramrakha
Director

 

Heart Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
1 Ledborough Wood
Beaconsfield
Bucks
HP9 2DJ
United Kingdom

These financial statements were authorised for issue by the Board on 29 November 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

At 29 February 2024 the company's balance sheet showed a deficit on shareholders' funds of £124,166. The company relies on the support of its director's and related companies. The directors consider that this support will continue for a period of twelve months from the date of the approval of these accounts. The directors therefore believe that it is appropriate to prepare these accounts on a going concern basis and no adjustments have been made which would be require if that basis were to be inappropriate.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity; and
- specific criteria have been met for each of the company's activities.

 

Heart Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

Straight line @ 33%

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Application Software

Straight line over 10 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Heart Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

3

Loss before tax

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

1,420

1,184

Amortisation expense

5,188

5,188

4

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

5

Intangible assets

Other intangible assets
 £

Total
£

Cost or valuation

At 1 March 2023

51,880

51,880

At 29 February 2024

51,880

51,880

Amortisation

At 1 March 2023

23,191

23,191

Amortisation charge

5,188

5,188

At 29 February 2024

28,379

28,379

Carrying amount

At 29 February 2024

23,501

23,501

At 28 February 2023

28,689

28,689

 

Heart Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

6

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 March 2023

8,683

8,683

At 29 February 2024

8,683

8,683

Depreciation

At 1 March 2023

5,606

5,606

Charge for the year

1,420

1,420

At 29 February 2024

7,026

7,026

Carrying amount

At 29 February 2024

1,657

1,657

At 28 February 2023

3,077

3,077

7

Debtors

Current

2024
£

2023
£

Trade debtors

-

79

Other debtors

2

2

 

2

81

 

Heart Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

8

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

1,740

1,740

Other creditors

193,816

190,371

195,556

192,111

9

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Original of £1 each

2

2

2

2

       

10

Related party transactions

Summary of transactions with entities with joint control or significant interest

Dr P Ramrakha Limited
(A company controlled by one of the directors)

The Chiltern Hills Heart Clinic Limited
(A company controlled by one of the directors)

 Provision of a working capital loan with no interest or fixed date of repayment
 

Expenditure with and payables to related parties

2024

Entities with joint control or significant influence
£

Amounts payable to related party

177,935

2023

Entities with joint control or significant influence
£

Amounts payable to related party

175,523